Bioprocess Analyzers Market Report 2026

Bioprocess Analyzers Market Overview

• Bioprocess Analyzers market size has reached to $2.18 billion in 2025 • Expected to grow to $3.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.6% • Growth Driver: Impact Of Rising Demand For Biopharmaceuticals On The Bioprocess Analyzers Market • Market Trend: Advancements In Real-Time Monitoring Platforms For Bioprocess Analyzers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioprocess Analyzers Market?

Bioprocess analyzers refer to analytical devices or systems designed to track, examine, and regulate a range of factors and procedures related to the manufacturing of biopharmaceuticals, bioprocessing, and biotechnology. These analyzers are used in various sectors to guarantee the effectiveness and quality of bioprocessing activities and allow for real-time monitoring and control of critical parameters. The main types of bioprocess analyzer products are instruments and consumables. Instruments are indispensable tools in bioprocessing, enabling the accurate measurement, analysis, control, and optimization of bioprocesses to achieve desired outcomes in terms of product yield, quality, and efficiency. These are used for various applications, such as antibiotics, recombinant proteins, biosimilars, and others, by several end-users, including biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and others.

What Is The Bioprocess Analyzers Market Growth Forecast?

The bioprocess analyzers market size is expected to see strong growth in the next few years. It will grow to $3.35 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to expansion of personalized medicine, integration of ai in bioprocessing, demand for continuous manufacturing, growth of contract manufacturing organizations (cmos), development of miniaturized analytical systems. Major trends in the forecast period include real-time bioprocess monitoring, process analytical technology (pat) integration, high-throughput screening & automation, advanced sensor development, quality-by-design (qbd) implementation.

What Is The Driver Of The Bioprocess Analyzers Market?

The rise in demand for biopharmaceuticals is expected to propel the growth of the bioprocess analyzer market going forward. Biopharmaceuticals refers to pharmaceuticals made from biological sources, such as living things or their parts. The biopharmaceutical industry is on the rise due to creative research and development efforts that result in the creation of novel biologics and biosimilars. Bioprocess analyzers are used to monitor various parameters during the production of biopharmaceuticals, such as cell growth, protein expression, and product purity. For instance, in January 2024, according to IQVIA, a US-based provider of biopharmaceutical development services, the spending on global biotech is expected to exceed $892 billion by 2028. Therefore, rise in demand for biopharmaceuticals will drive the growth of bioprocess analyzer industry.

Key Players In The Global Bioprocess Analyzers Market

Major companies operating in the bioprocess analyzers market are Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, MilliporeSigma, Sartorius AG, Beckman Coulter Inc., Waters Corporation, Bio-Rad Laboratories, Bruker Corporation, Agilent Technologies, GE Healthcare, Pall Corporation, HORIBA Ltd., Nova Biomedical, Hamilton Company, BioTek Instruments, PerkinElmer Inc, Analytik Jena AG, Eppendorf AG, Metrohm AG, Zymo Research Corporation, Macherey-Nagel GmbH & Co. KG

Global Bioprocess Analyzers Market Trends and Insights

The major companies operating in bioprocess analyzers are focusing on developing advanced solutions, such as optical in-line analyzers, to gain a competitive edge in the market. Optical in-line analyzers refer to instruments that utilize optical technology to provide real-time monitoring and analysis of critical parameters in bioprocessing applications. For instance, in September 2023, 908 Devices Inc., a US-based chemical and biochemical analysis company, launched MAVERICK, an advanced optical in-line analyzer that provides real-time monitoring and control of essential factors such as glucose, lactate, and total biomass in mammalian cell cultures. Biopharmaceutical experts can utilize the device's comprehensive process fingerprint data to fine-tune large-scale bioprocesses. Its user-friendly design simplifies tasks for scientists and engineers, accelerating the development of cell culture media and the creation of effective feeding and control plans. It uses Raman spectroscopy to measure various important process parameters in real time, including glucose, lactate, and biomass, in bioreactors. Maverick is intended to improve process comprehension, optimize performance, and ensure batch-to-batch reproducibility in cell culture automation for biologic production with the CHO (Chinese hamster ovary) or HEK293 (human embryonic kidney 293) mammalian cell lines and multiple medium types.

What Are Latest Mergers And Acquisitions In The Bioprocess Analyzers Market?

In June 2023, Waters Corporation, a US-based analytical technologies company, expanded its collaboration with Sartorius, to deliver comprehensive bioanalytics solutions for downstream biomanufacturing. The partnership aims to enhance process efficiency, ensure product quality, and accelerate biologics development by integrating advanced analytical platforms and workflow solutions, supporting innovation and growth in the biopharmaceutical manufacturing sector. Sartorius is a Germany-based life sciences company specializing in bioprocessing and laboratory technologies.

What Defines the Bioprocess Analyzers Market?

The bioprocess analyzers market consists of sales of biosensors, spectroscopic sensors, spectrophotometers, and biochemical analyzers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Bioprocess Analyzers Market Report 2026?

The bioprocess analyzers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the bioprocess analyzers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.